On August 10th 2021, the International Society for Cardiovascular Translational Research (ISCTR), the Arizona Bioindustry Association (AZBio), and the University of Arizona James E. Rogers College of Law, Health Law & Policy Program partnered to present an educational webinar on Medical Device Development: Business Planning & Fundraising.Continue reading
Category Archives: AZBio News
Startup with an Innovative Imaging System Wins Sponsorship at The University of Arizona Center for Innovation Fueled by Concord General Contracting
TUCSON, Ariz.– The University of Arizona Center for Innovation (UACI) is pleased to announce that QScint Imaging Solutions, LLC. has won the UACI Sponsored Launch Fueled by Concord General Contracting competition.
QScint Imaging Solutions, LLC. manufactures iQID charged-particle digital autoradiography imaging systems for use in radiopharmaceutical drug development, geological studies, and nuclear forensics applications.
Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals
Other fully vaccinated individuals do not need an additional vaccine dose right now.
The NSF Awards ZelosDx $255,000 For the Development of WINDOW INTO THE BRAIN Biomarker Technology
TUCSON, AZ, July 27, 2021 – ZelosDx, Inc. announced today that the company is the recipient of a Small Business Innovation Research (SBIR) Phase l Award from the National Science Foundation (NSF) for a grant entitled, “ Phagocytic Cells in Peripheral Blood as a Novel Diagnostic Tool for Brain Health”. The company will receive a one-year grant of up to $255,000 to expand the company’s pioneering biomarker research.Continue reading
Wexford Innovation Labs Coming to Phoenix
Wexford Science & Technology to Open Entrepreneurial Spaces in 850 PBC
SEC approves Nasdaq’s Board Diversity Rule
Nasdaq’s Board Diversity Rule, which was approved by the SEC on August 6, 2021, is a disclosure standard
designed to encourage a minimum board diversity objective for companies and provide stakeholders with
consistent, comparable disclosures concerning a company’s current board composition. A copy of the approval order can be viewed here.
TGen leads international team to characterize blood-based clues of Parkinson’s Disease
Immune system alterations could provide a path for future diagnostics and studies of this progressively debilitating neurological disease
Humabiologics & Allegro 3D partner to provide human bioinks for rapid high throughput bioprinting and tissue models
The convergence of the world’s first human bioinks and the most advanced digital light processing (DLP)-based bioprinter for direct printing in multiwell plates will accelerate high-throughput manufacturing of advanced human tissues for cell culture, drug screening, therapeutics and regenerative medicine. Continue reading
Helios Scholars at TGen learn teamwork, technique and tenacity
Aug. 3 symposium caps 8-week internship of real-life biomedical research sponsored by Helios Education FoundationContinue reading
CyVerse Receives $1.3M to Provide Cyberinfrastructure and Training for New NSF Artificial Intelligence Institute
CyVerse will provide computational infrastructure, data science and education to integrate the efforts of other partners of the NSF’s new AI Institute for Resilient Agriculture.